These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3971404)

  • 1. [Improvement of the hepatoprotective effect of silymarin when administered by injection].
    Rezábek K; Seda M; Procházka V
    Cas Lek Cesk; 1985 Feb; 124(6):170-2. PubMed ID: 3971404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of influencing the hepatotoxicity of chemotherapeutics by the use of silymarin].
    Barton P; Krejcí V; Blazek M
    Cas Lek Cesk; 1985 Feb; 124(6):173-5. PubMed ID: 3971405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 4. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetaminophen hepatotoxicity in rats is attenuated by silybin dihemisuccinate.
    Campos R; Garrido A; Guerra R; Valenzuela A
    Prog Clin Biol Res; 1988; 280():375-8. PubMed ID: 3174702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of the anti-hepatotoxic effect of silymarin in CCl4-and deoxycholate-induced liver damage in the rat].
    Schriewer H; Badde R; Roth G; Rauen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:157-8. PubMed ID: 4740686
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: II. alterations in thymic differentiation correlate with changes in c-myc gene expression.
    Johnson VJ; Osuchowski MF; He Q; Sharma RP
    Planta Med; 2002 Nov; 68(11):961-5. PubMed ID: 12451483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The anti-hepatotoxic effect of parenterally administered silymarin in CCl4-induced liver damage of the rat].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:148-9. PubMed ID: 4740683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology].
    Vogel G; Trost W; Braatz R; Odenthal KP; Brüsewitz G; Antweiler H; Seeger R
    Arzneimittelforschung; 1975 Jan; 25(1):82-9. PubMed ID: 1173772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion].
    Skakun NP; Stepanova NIu
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):781-4. PubMed ID: 3789688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative antagonism of phalloidin induced liver damage with silymarin as a model of an antihepatotoxic therapy].
    Vogel G; Temme I
    Arzneimittelforschung; 1969 Apr; 19(4):613-5. PubMed ID: 5819161
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of silymarin on experimental phalloidine poisoning.
    Desplaces A; Choppin J; Vogel G; Trost W
    Arzneimittelforschung; 1975 Jan; 25(1):89-96. PubMed ID: 125090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the hepatoprotector action of natural flavonoids].
    Dorkina EG
    Eksp Klin Farmakol; 2004; 67(6):41-4. PubMed ID: 15707014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.
    Wang M; Xie T; Chang Z; Wang L; Xie X; Kou Y; Xu H; Gao X
    PLoS One; 2015; 10(12):e0143625. PubMed ID: 26674103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 18. Putative effect of silymarin on sawfly (Arge pullata)-induced hepatotoxicosis in sheep.
    Thamsborg SM; Jørgensen ; Brummerstedt E; Bjerregard J
    Vet Hum Toxicol; 1996 Apr; 38(2):89-91. PubMed ID: 8693692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on the effect of hepatoprotective compounds.
    Lapis K; Jeney A; Divald A; Vajta G; Zalatnai A; Schaff Z
    Tokai J Exp Clin Med; 1986; 11 Suppl():135-45. PubMed ID: 3330627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatoprotective properties of silymarin].
    Matveev AV; Koniaeva EI; Kurchenko VP; Shchekatikhina AS
    Eksp Klin Gastroenterol; 2011; (2):130-5. PubMed ID: 21560654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.